A detailed history of Gamma Investing LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Gamma Investing LLC holds 2,490 shares of CORT stock, worth $129,903. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,490
Previous 1,343 85.41%
Holding current value
$129,903
Previous $43.6 Million 164.1%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$29.51 - $46.26 $33,847 - $53,060
1,147 Added 85.41%
2,490 $115 Million
Q2 2024

Jul 02, 2024

BUY
$22.21 - $34.48 $2,776 - $4,310
125 Added 10.26%
1,343 $43.6 Million
Q1 2024

Apr 05, 2024

BUY
$21.1 - $27.46 $12,216 - $15,899
579 Added 90.61%
1,218 $30.7 Million
Q4 2023

Feb 01, 2024

BUY
$24.82 - $32.88 $15,859 - $21,010
639 New
639 $13.5 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.